The role of induction androgen deprivation prior to radical prostatectomy

M. S. Soloway, R. Watson

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

In patients with localised prostate cancer and a life expectancy of at least 10 years, radical prostatectomy is increasingly being performed. Pre-operative clinical staging of prostate cancer is, however, inaccurate with around 10-20% of clinical T1, 10-30% of clinical T2(a), and 30-60% of clinical T2(b) cases having tumour at the surgical margin. There is no documented best treatment for patients with a positive surgical margin. Options include close observation, adjuvant radiation therapy or androgen deprivation. The role of induction androgen deprivation has, therefore, evolved in an attempt to improve upon the cure rate for radical prostatectomy, and in this review results from clinical trials are discussed. In the largest United States randomised trial in patients with stage T2(b) prostate cancer, pre-operative androgen deprivation resulted in a significantly lower rate of positive surgical margins, normalisation of prostate-specific antigen and a decrease in the size of the prostate. Sufficient follow-up is required from all of the completed prospective randomised trials before pre-operative androgen deprivation can be justified in all T2(b) patients.

Original languageEnglish
Pages (from-to)114-118
Number of pages5
JournalEuropean Urology
Volume29
Issue numberSUPPL. 2
StatePublished - May 1 1996
Externally publishedYes

Fingerprint

Prostatectomy
Androgens
Prostatic Neoplasms
Prostate-Specific Antigen
Life Expectancy
Prostate
Radiotherapy
Observation
Clinical Trials
Margins of Excision
Neoplasms
Therapeutics

Keywords

  • Induction androgen deprivation
  • Neoadjuvant therapy
  • Prostate cancer
  • Radical prostatectomy

ASJC Scopus subject areas

  • Urology

Cite this

Soloway, M. S., & Watson, R. (1996). The role of induction androgen deprivation prior to radical prostatectomy. European Urology, 29(SUPPL. 2), 114-118.

The role of induction androgen deprivation prior to radical prostatectomy. / Soloway, M. S.; Watson, R.

In: European Urology, Vol. 29, No. SUPPL. 2, 01.05.1996, p. 114-118.

Research output: Contribution to journalArticle

Soloway, MS & Watson, R 1996, 'The role of induction androgen deprivation prior to radical prostatectomy', European Urology, vol. 29, no. SUPPL. 2, pp. 114-118.
Soloway, M. S. ; Watson, R. / The role of induction androgen deprivation prior to radical prostatectomy. In: European Urology. 1996 ; Vol. 29, No. SUPPL. 2. pp. 114-118.
@article{27a31603c23f496b81db49681ce115ab,
title = "The role of induction androgen deprivation prior to radical prostatectomy",
abstract = "In patients with localised prostate cancer and a life expectancy of at least 10 years, radical prostatectomy is increasingly being performed. Pre-operative clinical staging of prostate cancer is, however, inaccurate with around 10-20{\%} of clinical T1, 10-30{\%} of clinical T2(a), and 30-60{\%} of clinical T2(b) cases having tumour at the surgical margin. There is no documented best treatment for patients with a positive surgical margin. Options include close observation, adjuvant radiation therapy or androgen deprivation. The role of induction androgen deprivation has, therefore, evolved in an attempt to improve upon the cure rate for radical prostatectomy, and in this review results from clinical trials are discussed. In the largest United States randomised trial in patients with stage T2(b) prostate cancer, pre-operative androgen deprivation resulted in a significantly lower rate of positive surgical margins, normalisation of prostate-specific antigen and a decrease in the size of the prostate. Sufficient follow-up is required from all of the completed prospective randomised trials before pre-operative androgen deprivation can be justified in all T2(b) patients.",
keywords = "Induction androgen deprivation, Neoadjuvant therapy, Prostate cancer, Radical prostatectomy",
author = "Soloway, {M. S.} and R. Watson",
year = "1996",
month = "5",
day = "1",
language = "English",
volume = "29",
pages = "114--118",
journal = "European Urology",
issn = "0302-2838",
publisher = "Elsevier",
number = "SUPPL. 2",

}

TY - JOUR

T1 - The role of induction androgen deprivation prior to radical prostatectomy

AU - Soloway, M. S.

AU - Watson, R.

PY - 1996/5/1

Y1 - 1996/5/1

N2 - In patients with localised prostate cancer and a life expectancy of at least 10 years, radical prostatectomy is increasingly being performed. Pre-operative clinical staging of prostate cancer is, however, inaccurate with around 10-20% of clinical T1, 10-30% of clinical T2(a), and 30-60% of clinical T2(b) cases having tumour at the surgical margin. There is no documented best treatment for patients with a positive surgical margin. Options include close observation, adjuvant radiation therapy or androgen deprivation. The role of induction androgen deprivation has, therefore, evolved in an attempt to improve upon the cure rate for radical prostatectomy, and in this review results from clinical trials are discussed. In the largest United States randomised trial in patients with stage T2(b) prostate cancer, pre-operative androgen deprivation resulted in a significantly lower rate of positive surgical margins, normalisation of prostate-specific antigen and a decrease in the size of the prostate. Sufficient follow-up is required from all of the completed prospective randomised trials before pre-operative androgen deprivation can be justified in all T2(b) patients.

AB - In patients with localised prostate cancer and a life expectancy of at least 10 years, radical prostatectomy is increasingly being performed. Pre-operative clinical staging of prostate cancer is, however, inaccurate with around 10-20% of clinical T1, 10-30% of clinical T2(a), and 30-60% of clinical T2(b) cases having tumour at the surgical margin. There is no documented best treatment for patients with a positive surgical margin. Options include close observation, adjuvant radiation therapy or androgen deprivation. The role of induction androgen deprivation has, therefore, evolved in an attempt to improve upon the cure rate for radical prostatectomy, and in this review results from clinical trials are discussed. In the largest United States randomised trial in patients with stage T2(b) prostate cancer, pre-operative androgen deprivation resulted in a significantly lower rate of positive surgical margins, normalisation of prostate-specific antigen and a decrease in the size of the prostate. Sufficient follow-up is required from all of the completed prospective randomised trials before pre-operative androgen deprivation can be justified in all T2(b) patients.

KW - Induction androgen deprivation

KW - Neoadjuvant therapy

KW - Prostate cancer

KW - Radical prostatectomy

UR - http://www.scopus.com/inward/record.url?scp=0029921923&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029921923&partnerID=8YFLogxK

M3 - Article

C2 - 8717473

AN - SCOPUS:0029921923

VL - 29

SP - 114

EP - 118

JO - European Urology

JF - European Urology

SN - 0302-2838

IS - SUPPL. 2

ER -